BioLargo
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioLargo generated cash of -$2,365,000, which is more than the previous year. Cash used in financing activities reached the amount of $4,659,000 last year. Net change in cash is therefore $1,688,000.
Cash Flow
| 2014 | -1.71M | 0 | 1.78M |
|---|---|---|---|
| 2015 | -1.88M | 0 | 3.53M |
| 2016 | -3.72M | -61.93K | 3.97M |
| 2017 | -4.28M | -28.67K | 3.37M |
| 2018 | -3.89M | -58K | 3.64M |
| 2019 | -4.42M | -35K | 4.46M |
| 2020 | -4.15M | -123K | 4.34M |
| 2021 | -3.93M | -34K | 4.23M |
| 2022 | -2.76M | -271K | 3.95M |
| 2023 | -2.36M | -478K | 4.65M |
BLGO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.85M | 962K | 716K | 655K | 655K | 990K | 1.91M | 1.76M | 154.46K | 92.43K |
Operating activities | ||||||||||
Net income | -3.50M | -5.13M | -6.89M | -9.7M | -11.44M | -10.69M | -9.54M | -8.07M | -5.07M | -3.73M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 172K | 45K | 20K | 58K | 65K | 50K | 29.84K | 15.88K | 10.92K | 10.92K |
Stock-based compensation expense | 2.12M | 2.07M | 1.87M | 2.45M | 1.52M | 0 | 1.10M | 751.11K | 734.34K | 483.41K |
| Deferred income tax benefit | 2.12M | 2.07M | 1.87M | 2.45M | 1.52M | 0 | 1.10M | 751.11K | 734.34K | 483.41K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.63M | -551K | -29K | -142K | -121K | -163K | -28.91K | -26.56K | -35.81K | -1.68K |
Inventories | -89K | -35K | 36K | -261K | 9K | 28K | -19.52K | 2.98K | -11.92K | 4.31K |
Accounts payable | 465K | 390K | 122K | 458K | 123K | 284K | 114.40K | -124.88K | -114.72K | 94.25K |
Cash generated by operating activities | -2.36M | -2.76M | -3.93M | -4.15M | -4.42M | -3.89M | -4.28M | -3.72M | -1.88M | -1.71M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -100K | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -478K | -271K | -34K | -23K | -35K | -58K | -28.67K | -61.93K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | -100K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -478K | -271K | -34K | -123K | -35K | -58K | -28.67K | -61.93K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 4.62M | 3.61M | 4.93M | 3.63M | 661K | 1.84M | 1.26M | 864.00K | 750K | 1.58M |
Payments for dividends | -242K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -40K | 0 | 0 | 0 |
Repayments of term debt | 38K | 74K | -865K | -61K | 1.37M | -243K | 1.99M | -3.10M | 2.80M | 0 |
Cash used in financing activities | 4.65M | 3.95M | 4.23M | 4.34M | 4.46M | 3.64M | 3.37M | 3.97M | 3.53M | 1.78M |
Net Change In Cash | 1.68M | 889K | 246K | 61K | 0 | -335K | -919.69K | 147.03K | 1.60M | 62.02K |
Cash at end of period | 3.53M | 1.85M | 962K | 716K | 655K | 655K | 990.45K | 1.91M | 1.76M | 154.46K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |